Tissue mRNA expression of the glucocorticoid receptor and its splice variants in fatal critical illness

Clinical Endocrinology

Volumn 71, Issue 1, 2009, Pages 145-153

  Peeters, R P ^b   Hagendorf, A ^b   Vanhorebeek, I ^a   Visser, T J ^b   Klootwijk, W ^b   Mesotten, D ^a   Wouters, P J ^a   Koper, J W ^b   De Jong, F H ^b   Feelders, R A ^b   Lamberts, S W J ^b   Van Den Berghe, G ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ALPHA; GLUCOCORTICOID RECEPTOR BETA; GLUCOCORTICOID RECEPTOR DELTA; HYDROCORTISONE; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CADAVER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CRITICAL ILLNESS; FATALITY; FEMALE; HUMAN; HUMAN TISSUE; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INSULIN TREATMENT; INTENSIVE CARE; LIVER; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MUSCLE BIOPSY; MUSCLE TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN VARIANT; RANDOMIZED CONTROLLED TRIAL; RNA SPLICING;

AGED; AGED, 80 AND OVER; ALTERNATIVE SPLICING; CRITICAL ILLNESS; FEMALE; GENE EXPRESSION; GLUCOCORTICOIDS; HUMANS; INSULIN; INTENSIVE CARE UNITS; LIVER; MALE; MIDDLE AGED; MUSCLES; RECEPTORS, GLUCOCORTICOID;

EID: 66949170606     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03443.x     Document Type: Article

References (57)

1. Reincke, M., Allolio, B., Wurth, G. et al. (1993) The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone. Journal of Clinical Endocrinology and Metabolism, 77, 151 156.
2. Drucker, D. Shandling, M. (1985) Variable adrenocortical function in acute medical illness. Critical Care Medicine, 13, 477 479. (Pubitemid 15063833)
3. Drucker, D. McLaughlin, J. (1986) Adrenocortical dysfunction in acute medical illness. Critical Care Medicine, 14, 789 791. (Pubitemid 16003105)
4. Jurney, T.H., Cockrell, J.L. Jr., Lindberg, J.S. et al. (1987) Spectrum of serum cortisol response to ACTH in ICU patients. Correlation with degree of illness and mortality. Chest, 92, 292 295. (Pubitemid 17125833)
5. Parker, L.N., Levin, E.R. Lifrak, E.T. (1985) Evidence for adrenocortical adaptation to severe illness. Journal of Clinical Endocrinology and Metabolism, 60, 947 952. (Pubitemid 15085127)
6. Chrousos, G.P. (1995) The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. New England Journal of Medicine, 332, 1351 1362.
7. Rivier, C. Vale, W. (1983) Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin. Nature, 305, 325 327.
8. Van den Berghe, G. (2000) Novel insights into the neuroendocrinology of critical illness. European Journal of Endocrinology, 143, 1 13. (Pubitemid 30482194)
9. Bornstein, S.R. Chrousos, G.P. (1999) Clinical review 104. Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs. Journal of Clinical Endocrinology and Metabolism, 84, 1729 1736. (Pubitemid 30644284)
10. Vermes, I., Beishuizen, A., Hampsink, R.M. et al. (1995) Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: possible role of endothelin and atrial natriuretic hormone. Journal of Clinical Endocrinology and Metabolism, 80, 1238 1242.
11. Van den Berghe, G. (2002) Dynamic neuroendocrine responses to critical illness. Frontiers in Neuroendocrinology, 23, 370 391. (Pubitemid 35346212)
12. Van den Berghe, G. (2001) The neuroendocrine response to stress is a dynamic process. Best Practice and Research. Clinical Endocrinology and Metabolism, 15, 405 419. (Pubitemid 34884217)
13. Sam, S., Corbridge, T.C., Mokhlesi, B. et al. (2004) Cortisol levels and mortality in severe sepsis. Clinical Endocrinology, 60, 29 35. (Pubitemid 38183494)
14. Span, L.F., Hermus, A.R., Bartelink, A.K. et al. (1992) Adrenocortical function: an indicator of severity of disease and survival in chronic critically ill patients. Intensive Care Medicine, 18, 93 96.
15. Vanhorebeek, I., Peeters, R.P., Vander Perre, S. et al. (2006) Cortisol response to critical illness: effect of intensive insulin therapy. Journal of Clinical Endocrinology and Metabolism, 91, 3803 3813. (Pubitemid 44536847)
16. Annane, D., Sebille, V., Troche, G. et al. (2000) A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. Journal of the American Medical Association, 283, 1038 1045. (Pubitemid 30112218)
17. Annane, D., Sebille, V., Charpentier, C. et al. (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. Journal of the American Medical Association, 288, 862 871. (Pubitemid 34898534)
18. Minneci, P.C., Deans, K.J., Banks, S.M. et al. (2004) Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose. Annals of Internal Medicine, 141, 47 56.
19. DeRijk, R.H., Schaaf, M. de Kloet, E.R. (2002) Glucocorticoid receptor variants: clinical implications. Journal of Steroid Biochemistry and Molecular Biology, 81, 103 122. (Pubitemid 34879139)
20. Oakley, R.H., Jewell, C.M., Yudt, M.R. et al. (1999) The dominant negative activity of the human glucocorticoid receptor beta isoform. Specificity and mechanisms of action. Journal of Biological Chemistry, 274, 27857 27866.
21. Bamberger, C.M., Bamberger, A.M., de Castro, M. et al. (1995) Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. Journal of Clinical Investigation, 95, 2435 2441.
22. Hagendorf, A., Koper, J.W., de Jong, F.H. et al. (2005) Expression of the human glucocorticoid receptor splice variants alpha, beta, and P in peripheral blood mononuclear leukocytes in healthy controls and in patients with hyper- and hypocortisolism. Journal of Clinical Endocrinology and Metabolism, 90, 6237 6243. (Pubitemid 41606550)
23. de Lange, P., Segeren, C.M., Koper, J.W. et al. (2001) Expression in hematological malignancies of a glucocorticoid receptor splice variant that augments glucocorticoid receptor-mediated effects in transfected cells. Cancer Research, 61, 3937 3941. (Pubitemid 32720954)
24. Van den Berghe, G., Wouters, P., Weekers, F. et al. (2001) Intensive insulin therapy in critically ill patients. New England Journal of Medicine, 345, 1359 1367. (Pubitemid 34940724)
25. Knaus, W.A., Draper, E.A., Wagner, D.P. et al. (1985) APACHE II: a severity of disease classification system. Critical Care Medicine, 13, 818 829. (Pubitemid 15250137)
26. Keene, A.R. Cullen, D.J. (1983) Therapeutic intervention scoring system: update 1983. Critical Care Medicine, 11, 1 3.
27. Miranda, D.R., de Rijk, A. Schaufeli, W. (1996) Simplified therapeutic intervention scoring system: the TISS-28 items - results from a multicenter study. Critical Care Medicine, 24, 64 73.
28. Peeters, R.P., Wouters, P.J., Kaptein, E. et al. (2003) Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. Journal of Clinical Endocrinology and Metabolism, 88, 3202 3211. (Pubitemid 36877495)
29. Coolens, J.L., Van Baelen, H. Heyns, W. (1987) Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin. Journal of Steroid Biochemistry, 26, 197 202. (Pubitemid 17040122)
30. Czerny, T. (1996) High primer concentration improves PCR amplification from random pools. Nucleic Acids Research, 24, 985 986. (Pubitemid 26076210)
31. Pujols, L., Mullol, J., Roca-Ferrer, J. et al. (2002) Expression of glucocorticoid receptor alpha- and beta-isoforms in human cells and tissues. American Journal of Physiology. Cell Physiology, 283, C1324 C1331.
32. Dahia, P.L., Honegger, J., Reincke, M. et al. (1997) Expression of glucocorticoid receptor gene isoforms in corticotropin-secreting tumors. Journal of Clinical Endocrinology and Metabolism, 82, 1088 1093. (Pubitemid 27166647)
33. Hecht, K., Carlstedt-Duke, J., Stierna, P. et al. (1997) Evidence that the beta-isoform of the human glucocorticoid receptor does not act as a physiologically significant repressor. Journal of Biological Chemistry, 272, 26659 26664. (Pubitemid 27458890)
34. Oakley, R.H., Sar, M. Cidlowski, J.A. (1996) The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function. Journal of Biological Chemistry, 271, 9550 9559.
35. Pujols, L., Mullol, J., Perez, M. et al. (2001) Expression of the human glucocorticoid receptor alpha and beta isoforms in human respiratory epithelial cells and their regulation by dexamethasone. American Journal of Respiratory Cell and Molecular Biology, 24, 49 57. (Pubitemid 32099724)
36. Longui, C.A., Vottero, A., Adamson, P.C. et al. (2000) Low glucocorticoid receptor alpha/beta ratio in T-cell lymphoblastic leukemia. Hormone and Metabolic Research, 32, 401 406.
37. Strickland, I., Kisich, K., Hauk, P.J. et al. (2001) High constitutive glucocorticoid receptor beta in human neutrophils enables them to reduce their spontaneous rate of cell death in response to corticosteroids. Journal of Experimental Medicine, 193, 585 593. (Pubitemid 32539555)
38. de Castro, M., Elliot, S., Kino, T. et al. (1996) The non-ligand binding beta-isoform of the human glucocorticoid receptor (hGR beta): tissue levels, mechanism of action, and potential physiologic role. Molecular Medicine, 2, 597 607. (Pubitemid 26353108)
39. Webster, J.C., Oakley, R.H., Jewell, C.M. et al. (2001) Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance. Proceedings of the National Academy of Sciences of the United States of America, 98, 6865 6870. (Pubitemid 32538308)
40. Schaaf, M.J. Cidlowski, J.A. (2003) Molecular determinants of glucocorticoid receptor mobility in living cells: the importance of ligand affinity. Molecular and Cellular Biology, 23, 1922 1934. (Pubitemid 36278806)
41. Whorwood, C.B., Donovan, S.J., Wood, P.J. et al. (2001) Regulation of glucocorticoid receptor alpha and beta isoforms and type I, 11beta- hydroxysteroid dehydrogenase expression in human skeletal muscle cells: a key role in the pathogenesis of insulin resistance? Journal of Clinical Endocrinology and Metabolism, 86, 2296 2308. (Pubitemid 32472955)
42. Oakley, R.H., Webster, J.C., Sar, M. et al. (1997) Expression and subcellular distribution of the beta-isoform of the human glucocorticoid receptor. Endocrinology, 138, 5028 5038. (Pubitemid 27460944)
43. Lamberts, S.W., Bruining, H.A. de Jong, F.H. (1997) Corticosteroid therapy in severe illness. New England Journal of Medicine, 337, 1285 1292. (Pubitemid 27461285)
44. Cooper, M.S. Stewart, P.M. (2003) Corticosteroid insufficiency in acutely ill patients. New England Journal of Medicine, 348, 727 734. (Pubitemid 36237043)
45. Burchard, K. (2001) A review of the adrenal cortex and severe inflammation: quest of the 'eucorticoid' state. Journal of Trauma, 51, 800 814. (Pubitemid 33029310)
46. Rothwell, P.M. Lawler, P.G. (1995) Prediction of outcome in intensive care patients using endocrine parameters. Critical Care Medicine, 23, 78 83.
47. Cohen, J., Venkatesh, B., Galligan, J. et al. (2004) Salivary cortisol concentration in the intensive care population: correlation with plasma cortisol values. Anaesthesia and Intensive Care, 32, 843 845.
48. Prigent, H., Maxime, V. Annane, D. (2004) Clinical review: corticotherapy in sepsis. Critical Care Medicine, 8, 122 129. (Pubitemid 38436420)
49. The Veterans Administration Systemic Sepsis Cooperative Study Group (1987) Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. New England Journal of Medicine, 317, 659 665.
50. Cronin, L., Cook, D.J., Carlet, J. et al. (1995) Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Critical Care Medicine, 23, 1430 1439.
51. Bollaert, P.E., Charpentier, C., Levy, B. et al. (1998) Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Critical Care Medicine, 26, 645 650. (Pubitemid 28201409)
52. Briegel, J., Forst, H., Haller, M. et al. (1999) Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Critical Care Medicine, 27, 723 732. (Pubitemid 29218204)
53. Sprung, C.L., Annane, D., Keh, D. et al. (2008) Hydrocortisone therapy for patients with septic shock. New England Journal of Medicine, 358, 111 124.
54. Vig, E., Barrett, T.J. Vedeckis, W.V. (1994) Coordinate regulation of glucocorticoid receptor and C-jun mRNA levels: evidence for cross-talk between two signaling pathways at the transcriptional level. Molecular Endocrinology, 8, 1336 1346. (Pubitemid 24335077)
55. Burnstein, K.L., Jewell, C.M., Sar, M. et al. (1994) Intragenic sequences of the human glucocorticoid receptor complementary DNA mediate hormone-inducible receptor messenger RNA down-regulation through multiple mechanisms. Molecular Endocrinology, 8, 1764 1773.
56. Andersson, O., Cassel, T.N., Gronneberg, R. et al. (1999) In vivo modulation of glucocorticoid receptor mRNA by inhaled fluticasone propionate in bronchial mucosa and blood lymphocytes in subjects with mild asthma. Journal of Allergy and Clinical Immunology, 103, 595 600. (Pubitemid 29295564)
57. Andreae, J., Tripmacher, R., Weltrich, R. et al. (2001) Effect of glucocorticoid therapy on glucocorticoid receptors in children with autoimmune diseases. Pediatric Research, 49, 130 135. (Pubitemid 32015011)